Filing Flows › Globus Medical (GMED) › Q2 2026 › vs Q1 2026
Globus Medical (GMED) Q2 2026 vs Q1 2026 (quarter over quarter)
Globus Medical's revenue rose $29.8M (+4%) from $760M in Q1 2026 to $790M in Q2 2026. The biggest changes: Musculoskeletal Solutions +$30.6M (+4%); Enabling Technologies −$798K (-3%). Operating margin 23.1% against 19.8% (+3.3 pts).
Globus Medical, Q2 2026: revenue $790M (+6% year over year), operating margin 23.1%, net earnings $152M, operating cash flow $210M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 23.1% | 19.8% | +3.3 pts |
| Net margin | 19.2% | 16.4% | +2.8 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Musculoskeletal Solutions | $764M | $733M | $30.6M | +4% |
| Enabling Technologies | $26.1M | $26.9M | −$798K | -3% |
| Revenue | $790M | $760M | $29.8M | +4% |
| Other income, net | $7.4M | $6.7M | $699K | +10% |
| Operating profit | $182M | $150M | $32.0M | +21% |
| Costs & expenses | $607M | $609M | −$2.3M | -0.4% |
| Pre-tax earnings | $190M | $157M | $32.7M | +21% |
| Cost of revenue | $241M | $234M | $7.4M | +3% |
| Research & development | $36.3M | $36.5M | −$189K | -0.5% |
| SG&A | $287M | $298M | −$11.0M | -4% |
| Other operating costs | $42.6M | $41.1M | $1.5M | +4% |
| Net earnings | $152M | $124M | $27.3M | +22% |
| Income tax | $38.2M | $32.8M | $5.5M | +17% |
| Depreciation & amortization | $69.5M | $69.9M | −$357K | -0.5% |
| Share-based compensation | $13.4M | $12.6M | $766K | +6% |
| Working capital & other | $24.7M | $4.4M | $20.3M | +460% |
| Operating cash flow | $210M | $202M | $7.4M | +4% |
Questions
How much did Globus Medical's revenue grow quarter over quarter in Q2 2026?
Globus Medical's revenue rose $29.8M (+4%) from $760M in Q1 2026 to $790M in Q2 2026.
What drove Globus Medical's revenue change in Q2 2026?
Musculoskeletal Solutions +$30.6M (+4%); Enabling Technologies −$798K (-3%).